One Health Company announced a collaboration with IDEXX Laboratories, Inc. IDEXX Reference Laboratories will offer the FidoCure Next Generation DNA Sequencing Test to its veterinary customers in the United States and Canada later this month. The collaboration, which expands IDEXX's cancer care management portfolio, further enables veterinarians to deliver personalized care to their cancer patients by expanding access to FidoCure's precision medicine platform.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
499.3 USD | +2.06% | +4.82% | -10.04% |
04-01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
04-01 | Elanco appoints two directors after settling with activist Ancora | RE |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- One Health Company Collaborates with IDEXX to Expand Access to FidoCure® Precision Medicine Platform